Angelini Ventures
Headquarter
Sacramento, California
Milestones
Founded: 2016
Invested: 2025
CEO
Tara Nickerson
Vertical
Biotech
Board Participation
Fabrizio Calisti
Therini Bio is a clinical-stage biotech company developing immunotherapies for neuroinflammation in diseases driven by vascular dysfunction. Therini is developing a pipeline of potential first-in-class therapies selectively targeting toxic fibrin accumulation for diseases, including Alzheimer’s disease and Diabetic Macular Edema, where destructive neuroinflammation plays a central role in the disease process.
Related news: